Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edge
- PMID: 16703305
- DOI: 10.1007/s15010-006-6206-1
Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edge
Similar articles
-
CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature.Eur J Med Res. 2007 Oct 15;12(9):409-17. Eur J Med Res. 2007. PMID: 17933722 Review.
-
[Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker].Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:23-7. doi: 10.1016/s0213-005x(08)76560-1. Enferm Infecc Microbiol Clin. 2008. PMID: 19133218 Review. Spanish.
-
CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1.Eur J Med Res. 2007 Oct 15;12(9):427-34. Eur J Med Res. 2007. PMID: 17933724 Review.
-
Two new drugs for HIV infection.Med Lett Drugs Ther. 2008 Jan 14;50(1277):2-4. Med Lett Drugs Ther. 2008. PMID: 18197163 No abstract available.
-
[New antiretroviral drug classes in HIV therapy].MMW Fortschr Med. 2009 Apr 30;151(18):64-6. MMW Fortschr Med. 2009. PMID: 19769081 German. No abstract available.
Cited by
-
Is gene therapy a good therapeutic approach for HIV-positive patients?Genet Vaccines Ther. 2007 Feb 14;5:5. doi: 10.1186/1479-0556-5-5. Genet Vaccines Ther. 2007. PMID: 17300725 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical